VIROPHARMA INC
- CIK: 0000946840
- EIN: 23-2789550
- Business address: 730 STOCKTON DRIVE, EXTON, Pennsylvania, 19341
Information
Mailing address
730 STOCKTON DRIVE, EXTON, Delaware, 19341Phone
6104587300State location
PennsylvaniaState of incorporation
DelawareFiscal year end
December 31SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONSFilings
N/A
About VIROPHARMA INC
VIROPHARMA INC (CIK: 0000946840) is an American company incorporated in the state of Pennsylvania. Head office is located at 730 STOCKTON DRIVE, EXTON, Pennsylvania, 19341. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. VIROPHARMA INC is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Kirby John J. | 0001556327 | Aug-20-2012 | officer: V.P., Chief Accounting Officer |
| McHugh Julie | 0001487179 | Jan-03-2012 | director |
| DOUGHERTY MICHAEL R | 0001033516 | Feb-21-2011 | director |
| BROOKE PAUL A | 0001175940 | Feb-21-2011 | director |
| PIEN HOWARD H | 0001187152 | Feb-21-2011 | director |
| Leone John R | 0001301047 | Feb-21-2011 | director |
| Fletcher Robert C. | 0001508231 | Jan-01-2011 | officer: V.P., Business Development |
| DOYLE THOMAS F | 0001187172 | Jun-07-2010 | officer: VP Strategic Initiatives |
| Broom Colin MD | 0001289946 | Jun-07-2010 | officer: VP & Chief Scientific Officer |
| Rowland Charles A Jr | 0001383292 | Jun-07-2010 | officer: VP, Chief Financial Officer |
| Pietrusko Robert | 0001398219 | Jun-07-2010 | officer: VP, Regulatory & Quality |
| Wolf John Peter III | 0001421915 | Jun-07-2010 | officer: VP, General Counsel |
| Morris Richard Steven | 0001432303 | Jun-07-2010 | officer: Chief Accounting Officer |
| GLASER ROBERT | 0001187187 | May-27-2010 | director |
| DE ROSEN MICHEL | 0001187148 | Aug-16-2007 | director, officer: Chief Executive Officer |
| MILANO VINCENT | 0001187159 | Aug-16-2007 | officer: VP, COO & CFO |
| SOLAND DANIEL B | 0001318485 | Aug-16-2007 | officer: VP, Chief Commercial Officer |
| CLAYPOOL WILLIAM D MD | 0001273313 | Aug-15-2007 | director |
| BAKER JULIAN | 0001087939 | May-02-2005 | 10 percent owner |
| BAKER FELIX | 0001087940 | May-02-2005 | 10 percent owner |
| Baker Biotech Capital II (GP), LLC | 0001244386 | May-02-2005 | 10 percent owner |
| Baker Biotech Capital (GP), LLC | 0001244389 | May-02-2005 | 10 percent owner |
| Baker Bros. Capital (GP), LLC | 0001244390 | May-02-2005 | 10 percent owner |
| Baker / Tisch Capital (GP), LLC | 0001244392 | May-02-2005 | 10 percent owner |
| Baker Biotech Capital II (Z) (GP), LLC | 0001307726 | May-02-2005 | 10 percent owner |
| Baker Biotech Capital III (Z) (GP), LLC | 0001307728 | May-02-2005 | 10 percent owner |
| Baker Biotech Capital III (GP), LLC | 0001307729 | May-02-2005 | 10 percent owner |
| 14159 capital (GP), LLC | 0001317493 | May-02-2005 | 10 percent owner |
| Tarnoff Joshua M | 0001300080 | Jan-21-2005 | officer: VP, Commerical Operations |
| BALDINO FRANK JR | 0001187154 | Jan-12-2004 | director |
| AVENTIS INC | 0000217028 | Nov-03-2003 | other: Indirect Owner |
| AVENITS HOLDINGS INC | 0001267075 | Nov-03-2003 | other: Indirect Owner |
| AVENTIS PHARMACEUTICALS INC | 0001267093 | Nov-03-2003 | 10 percent owner |
| FARLEY RICHARD | 0001187156 | Jul-22-2003 | officer: VP, Human Resources |
| MCKINLAY MARK | 0001187161 | Jul-22-2003 | officer: VP, Research & Development |
| COLLETT MARC | 0001208973 | Jul-22-2003 | officer: VP, Drug Discovery |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by VIROPHARMA INC
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| SC TO-I/A | Document | Amendment to Issuer tender offer statement Acc-no: 0000950103-14-001310 (34 Act) Size: KB |
Feb-25-2014 | 14638935 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000935836-14-000116 (34 Act) Size: KB |
Feb-14-2014 | 14619315 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001144204-14-009650 (34 Act) Size: KB |
Feb-14-2014 | 14615653 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-14-002663 (34 Act) Size: KB |
Feb-14-2014 | 14610327 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000932471-14-004323 (34 Act) Size: KB |
Feb-12-2014 | 14598458 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001305227-14-000004 (34 Act) Size: KB |
Feb-10-2014 | 14589835 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001167674-14-000998 (34 Act) Size: KB |
Feb-10-2014 | 14589341 |
| 15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950103-14-000774 (34 Act) Size: KB |
Feb-04-2014 | 14572783 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003263 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003262 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003260 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003258 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003256 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003254 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003252 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003250 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003248 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003246 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003244 ( Act) Size: 0 KB |
Jan-28-2014 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001127602-14-003242 ( Act) Size: 0 KB |
Jan-28-2014 |
Recent 20 filings. View all VIROPHARMA INC filings
Reviews
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Frequently Asked Questions
Tags:
- VIROPHARMA INC overview
- VIROPHARMA INC job
- VIROPHARMA INC stock
- VIROPHARMA INC ownership
- VIROPHARMA INC CEO
- VIROPHARMA INC documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Metsera, Inc.
Update: Nov 21, 2024
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 